Lower rates of vitamin-K-antagonists usage are also related to physicians' and patients' comfort with novel oral anticoagulants.

Balci, Kevser Gülcihan; Balci, Mustafa Mücahit; Çetin, Elif Hande; Çelebi, Özlem Özcan; Maden, Orhan

Balci, Kevser Gülcihan; Balci, Mustafa Mücahit; Çetin, Elif Hande; Çelebi, Özlem Özcan; Maden, Orhan.

Afiliación

Balci KG; Department of Cardiology, Turkiye Yuksek Ihtisas Research and Education Hospital, Ankara, Turkey.
Balci MM; Department of Cardiology, Turkiye Yuksek Ihtisas Research and Education Hospital, Ankara, Turkey.
Çetin EH; Department of Cardiology, Turkiye Yuksek Ihtisas Research and Education Hospital, Ankara, Turkey.
Çelebi ÖÖ; Department of Cardiology, Turkiye Yuksek Ihtisas Research and Education Hospital, Ankara, Turkey.
Maden O; Department of Cardiology, Turkiye Yuksek Ihtisas Research and Education Hospital, Ankara, Turkey.

Acta Cardiol ; 75(1): 95, 2020 02.

Article en En | MEDLINE | ID: mdl-30650018

Asunto(s)

Anticoagulantes; Fibrinolíticos; Fibrinolíticos/uso terapéutico; Humanos; Vitaminas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrinolíticos / Anticoagulantes Límite: Humans Idioma: En Revista: Acta Cardiol Año: 2020 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google